Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma
| Autor: | Annie Guerin, Marjolaine Gauthier-Loiselle, Geneviève Gauthier, Lamis K. Eldjerou, Richard T. Maziarz, Yanni Hao, Simu K. Thomas |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Cancer Research medicine.medical_specialty Adolescent Office visits 03 medical and health sciences Young Adult 0302 clinical medicine immune system diseases hemic and lymphatic diseases Internal medicine Medicine Humans Transplantation Homologous In patient Intensive care medicine Aged Retrospective Studies Adult patients business.industry Hematopoietic Stem Cell Transplantation Hematology Health Care Costs Middle Aged medicine.disease Prognosis Lymphoma Survival Rate surgical procedures operative Cross-Sectional Studies Oncology 030220 oncology & carcinogenesis Allogeneic hsct Female Allogeneic hematopoietic stem cell transplant Lymphoma Large B-Cell Diffuse business Diffuse large B-cell lymphoma Resource utilization 030215 immunology Follow-Up Studies |
| Zdroj: | Leukemialymphoma. 59(5) |
| ISSN: | 1029-2403 |
| Popis: | This study describes short-term and long-term healthcare resource utilization (HRU) and costs following an allogeneic hematopoietic stem cell transplant (HSCT) in adult patients with diffuse large B-cell lymphoma (DLBCL) in a real-world setting. Among 101 patients with DLBCL receiving an allogeneic HSCT, HRU and direct healthcare costs for up to three years after the allogeneic HSCT are described. HRU and costs were substantial, with the most intensive HRU and highest healthcare costs observed during the first year after HSCT (38 inpatient days; 68 days with office visits and average healthcare costs of $455,741). Although HRU and costs decreased over time, they remained high even in the third year after HSCT (four inpatient days; 27 days with office visits and average healthcare costs of $72,957). Overall, this study showed that the economic burden following an allogeneic HSCT in DLBCL patients is significant. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|